755 related articles for article (PubMed ID: 9679845)
1. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
2. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
[TBL] [Abstract][Full Text] [Related]
7. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
10. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
Van den Berg NJ; Ossip MS; Hederos CA; Anttila H; Ribeiro BL; Davies PI
Pediatr Pulmonol; 2000 Aug; 30(2):97-105. PubMed ID: 10922131
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
Li JT; Ford LB; Chervinsky P; Weisberg SC; Kellerman DJ; Faulkner KG; Herje NE; Hamedani A; Harding SM; Shah T
J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
15. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
[TBL] [Abstract][Full Text] [Related]
17. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
18. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
19. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
Pieters WR; Stallaert RA; Prins J; Greefhorst AP; Bosman HG; van Uffelen R; Schreurs AJ; van Helmond JL; Janssen PG
J Asthma; 1998; 35(4):337-45. PubMed ID: 9669827
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
